What is the main purpose of this 8-K filing?

This 8-K filing is primarily to announce and provide Gilead Sciences' financial results for the third quarter ended September 30, 2016, through an accompanying press release.

Does this filing indicate any significant new business developments for Gilead?

No, this filing is focused on the company's routine quarterly financial reporting. It does not announce any new material business events, acquisitions, or strategic shifts beyond the financial performance of the quarter.

Where can I find the detailed financial results?

The detailed financial results, including both GAAP and non-GAAP figures and their reconciliations, are available in the press release filed as Exhibit 99.1 to this Form 8-K.

What is the difference between GAAP and non-GAAP financial information presented?

GAAP (Generally Accepted Accounting Principles) are standard accounting rules. Non-GAAP financial information is a supplemental measure used by management, which may exclude certain items or present results differently. While management finds it useful for internal planning and investors might find it insightful, it's not prepared under comprehensive GAAP rules and should be used in conjunction with, not instead of, GAAP data. A reconciliation is provided in the press release.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K on November 1, 2016, reporting its financial results for the third quarter ended September 30, 2016. The report primarily consists of a press release detailing these results, which includes both GAAP and non-GAAP financial information. Management believes the non-GAAP figures offer a useful supplemental view for investors, aiding in operational and financial planning. Investors should note that this filing is to inform about the quarterly results and does not represent a material event outside of normal financial reporting. The press release, attached as Exhibit 99.1, contains the detailed financial data and reconciliations between GAAP and non-GAAP measures. The company emphasizes that non-GAAP information should be considered alongside, not as a replacement for, its GAAP financial statements.

Key Highlights

1Gilead Sciences announced its Q3 2016 financial results on November 1, 2016.
2The filing includes a press release (Exhibit 99.1) detailing the financial performance for the quarter ended September 30, 2016.
3Both GAAP and non-GAAP financial information are presented for the quarter.
4Management views non-GAAP financial measures as useful for investors when analyzed with GAAP results.
5Non-GAAP financial information is used internally for operational, budgeting, and financial planning.
6Reconciliations between GAAP and non-GAAP financial data are available within the press release.
7The information provided is for informational purposes regarding financial results and is not considered 'filed' for purposes of Section 18 of the Exchange Act.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Nov 1, 2016)

Summary

Key Highlights

Frequently Asked Questions